1. Home
  2. KNDI vs ENTX Comparison

KNDI vs ENTX Comparison

Compare KNDI & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • ENTX
  • Stock Information
  • Founded
  • KNDI 2002
  • ENTX 2010
  • Country
  • KNDI China
  • ENTX Israel
  • Employees
  • KNDI N/A
  • ENTX N/A
  • Industry
  • KNDI Auto Manufacturing
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KNDI Consumer Discretionary
  • ENTX Health Care
  • Exchange
  • KNDI Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • KNDI 91.2M
  • ENTX 90.2M
  • IPO Year
  • KNDI N/A
  • ENTX 2018
  • Fundamental
  • Price
  • KNDI $1.21
  • ENTX $2.43
  • Analyst Decision
  • KNDI
  • ENTX Strong Buy
  • Analyst Count
  • KNDI 0
  • ENTX 1
  • Target Price
  • KNDI N/A
  • ENTX $10.00
  • AVG Volume (30 Days)
  • KNDI 113.0K
  • ENTX 83.2K
  • Earning Date
  • KNDI 03-13-2025
  • ENTX 03-07-2025
  • Dividend Yield
  • KNDI N/A
  • ENTX N/A
  • EPS Growth
  • KNDI N/A
  • ENTX N/A
  • EPS
  • KNDI N/A
  • ENTX N/A
  • Revenue
  • KNDI $118,127,232.00
  • ENTX $99,000.00
  • Revenue This Year
  • KNDI N/A
  • ENTX N/A
  • Revenue Next Year
  • KNDI N/A
  • ENTX N/A
  • P/E Ratio
  • KNDI N/A
  • ENTX N/A
  • Revenue Growth
  • KNDI N/A
  • ENTX 607.14
  • 52 Week Low
  • KNDI $0.89
  • ENTX $0.95
  • 52 Week High
  • KNDI $2.98
  • ENTX $3.35
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 60.15
  • ENTX 54.06
  • Support Level
  • KNDI $1.06
  • ENTX $2.21
  • Resistance Level
  • KNDI $1.12
  • ENTX $2.62
  • Average True Range (ATR)
  • KNDI 0.06
  • ENTX 0.21
  • MACD
  • KNDI 0.01
  • ENTX -0.01
  • Stochastic Oscillator
  • KNDI 90.00
  • ENTX 69.35

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: